The global market for point of care diagnostics products is expected to grow at a compound annual rate of 5.9%, from $19.0bn in 2020 to $25.3bn by 2025, according to a new report from Informa’s Meddevicetracker.
The COVID-19 pandemic has been responsible for a large part of this growth. In 2020, infectious disease testing which includes SARS-CoV-2 testing products accounted for $6,695m worth of sales.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?